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Neurofibromatosis 1 (NF1) is an autosomal genetic disorder caused by mutations in the 
NF1 gene that affects approximately 1 in 3000 people.1 Melanoma has been found in 0-
5.4% of NF1 patients.2 However, the incidence of melanoma in patients with NF1 in 
Japan has not been elucidated. Herein, we report a case of melanoma with NF1 and the 
incidence in our institution. 
A 95-year-old Japanese woman was referred to us for evaluation of a black nodule on her 
left hand. She had been diagnosed as having NF1 because of multiple cutaneous 
neurofibromas in addition to her family history. Physical examination revealed a black 
nodule, 3 × 2.5 cm in size, within a pigmented macule on the dorsal side of her left 
hand (Fig. 1a). Numerous cutaneous neurofibromas were also seen (Fig. 1b). 
Histopathology of the black nodule showed a proliferation of atypical tumor cells 
containing melanin granules invading into the deep dermis (Fig. 1c). Based on these 
findings, a diagnosis of acral melanoma (low to no chronic sun-induced damage) in a 
patient with NF1 was made. BRAF mutation was not found in the tumor cells. However, 
we could not perform mutation analysis for the NF1 gene because the patient was lost to 
follow-up. 
A retrospective study was conducted to reveal the relationship between melanoma and 





at the Dermatology Department of Tottori University Hospital from 2007 to 2019. The 
study protocol was approved by the Ethics Committee (1704A005). During the period, 
there were 170 NF1 patients (mean age, 27.25 years; age range, 0-95 years) and 157 
melanoma patients (mean age, 70.59 years; age range, 26-95 years). We identified only 
one patient with both diseases. The incidence in Japanese patients was about 0.6% in our 
institution.  
Since melanoma develops in approximately 1 or 2 in 100000 individuals in Japan, the 
incidence of melanoma in NF1 patients seems to be higher than that in normal individuals. 
However, the sample size in our study was relatively small because the data were obtained 
from a single institution. Guillot et al. reported the following features of melanoma with 
NF1: predominance for women, younger age (mean age, 33 years), large tumor thickness 
(mean thickness, 3.2 mm) and development from congenital nevus in 9 of 37 patients.3 
However, the prognosis is still unknown. In the present case, melanoma occurred on an 
unknown preceding lesion in an elderly woman. Recently, it has been reported that NF1 
is one of the driver genes for melanoma.4 Allelic loss of the NF1 gene (loss of 
heterozygosity) is likely to be related to the genesis of melanoma.5 In the present case, 
the melanoma cells did not have BRAF mutation. Therefore, inactivation of both copies 





that the risk of melanoma genesis is relatively low in individuals with NF1 in Japan. We 
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Figure 1.  
a) A black nodule in a pigmented macule.  
b) Multiple cutaneous neurofibromas were also seen. 
c) Histopathology showed a proliferation of atypical tumor cells containing melanin 
granules in the basal layer of the thickened epidermis invading into the deep dermis 
(tumor thickness, 3mm; HE, bar=500μm). 
